Page 9 - Introduction to FMT
P. 9

FMT Introduction





         Neuropsychiatric disorderseuropsychiatric disorders
        N


         A high incidence rate of constipation is found in Parkinson’s disease (PD) patients. Constipation can
         precede the onset of motor symptoms by more than 10 years[50], indicating the disease may start in the
         intestine. A man suffered from PD and characterized with the motor symptoms of marked pill-rolling
         hand tremors, micrographia, cogwheel rigidity, and chronic constipation[74]. He received antibiotic
         therapy (vancomycin, colchicine, and metronidazole) for his constipation and reported an improvement in
         gastrointestinal symptoms. After consistent therapy for 10 mo, his neurologic symptoms disappeared.
         This case cured by antibiotics suggests that the gut microbiota are involved in the pathogenesis of
         PD[74]. The results of symptomatic improvement in PD patients by FMT indicate a new way of thinking for
         clinicians[75].


         Both animal and clinical studies have shown that the pathogenesis of multiple sclerosis (MS) is associated
         with the intestinal microbiota[76,77]. Three patients with MS who underwent FMT for constipation achieved
         normal defecation and virtually complete normalization of neurological symptoms, thereby improving
         their quality of life[76]. Borody et al[78] reported a case of a young female patient with myoclonic
         dystonia and chronic diarrhea. The symptoms had co-developed since she was 6 years old and
         progressed in severity to a plateau. FMT resulted in a rapid improvement in diarrhea symptoms, a 90%
         improvement in her myoclonus dystonia symptoms, and, as a consequence of restoring her fine motor
         function, improving her ability to perform tasks that require dexterity, such as holding cups and fastening
         buttons[78].



         Autism is another condition in which intestinal microbiota is implicated. The onset of autism is often
         accompanied by intestinal dysfunction[79-81]. The first description of an association between autism and
         gastrointestinal syndrome began in 1971, with a report that 6 out of 15 autism patients had changed fecal
         character and defecation frequency[81]. Finegold et al[79] performed an intestinal flora study in
         regressive autism. It is compelling to observe that there were higher counts of Clostridium and
         Ruminococcus spp. in the stools of autistic children when compared to those in the control group. Nine
         clostridial species were found in autistic children, while only three were found in healthy children. The
         authors further observed histologic changes in the gastric and duodenal specimens. Moreover, significant
         higher numbers of non-spore- forming anaerobes and microaerophilic bacteria were found



         In autistic children. Based on the hypothesis that autism involves intestinal microbiota, Song et al[82]
         characterized Clostridia from the feces of autistic and control children. The data indicate that counts of
         Clostridium bolteae and clusters I and XI in autistic group are largely greater than those in control
         children. There was evidence of autistic symptom remission in two children after FMT[49]. Parallel results
         were also presented in five children who received daily cultured Bacteroidetes and Clostridia for several
         weeks.


















                                                 FMT Introduction
   4   5   6   7   8   9   10   11   12   13   14